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Abstract 26 
Classical Swine Fever Virus (CSFV) is an ongoing threat to the pig industry due to its high 27 
transmission and mortality rates associated with infection. Live attenuated vaccines such as the 28 
CSFV C strain vaccine are capable of protecting against infection within 5 days of vaccination, 29 
but the molecular mechanisms through which this early protection is mediated have yet to be 30 
established. In this study, we compared the response of pigs vaccinated with the C strain to 31 
non-vaccinated pigs both challenged with a pathogenic strain of CSFV. Analysis of 32 
transcriptomic data from the tonsils of these animals during the early stages after vaccination 33 
and challenge reveals a set of regulated genes that appear throughout the analysis. Many of 34 
these are linked to the ISG15 antiviral pathway suggesting it plays a key role in the rapid and 35 
early protection conferred by C strain vaccination. 36 
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Introduction 50 
Classical Swine Fever (CSF) is a contagious, haemorrhagic and often fatal disease of suidae 51 
such as pigs and wild boar, caused by the classical swine fever virus (CSFV).  CSFV is an 52 
enveloped, single stranded RNA virus that belongs to the pestivirus genus of the Flaviviridae 53 
family (Moennig, 2000).  The  positive-sense RNA genome of approximately 12.3kb is 54 
translated as a single polyprotein that is then cleaved by both host and native proteases to form 55 
11 proteins, 4 of which are structural components of the virion (Blome et al., 2017). Of these 56 
structural proteins 2 envelope glycoproteins, E1 and E2, are required for virus entry into the 57 
cell through clathrin-dependent, receptor-mediated endocytosis (Shi et al., 2016). The primary 58 
site of replication are the tonsils and oropharangyeal lymph nodes. From here, the virus is 59 
transported through the lymphatic system to the primary lymph nodes, where further rounds of 60 
replication occur until the virus eventually reaches all other organs in the body via the 61 
circulatory system (Gavier-Widen et al., 2012). Interferon signalling is a key component of 62 
how the innate immune system responds to challenge with CSFV. High levels of interferon-α 63 
(IFN- α) are a characteristic feature of acute disease (Summerfield and Ruggli, 2015). The 64 
levels of induction are associated with the virulence of the strain, with highly virulent strains 65 
inducing the highest levels (Durand et al., 2009a; Durand et al., 2009b; Renson et al., 2010). 66 
Despite the classical functional role of IFNs during viral infection, which is to induce the 67 
expression of a cohort of antiviral proteins, these high levels of IFN-α are counterproductive, 68 
do not limit virus replication, and lead to the development of disease-associated 69 
immunopathology observed through severe lymphoid depletion, lymphocyte apoptosis and 70 
thrombocytopenia. This immune dysfunction presents clinically as a viral haemorrhagic fever 71 
(Summerfield and Ruggli, 2015). 72 
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CSF is endemic to parts of South East Asia, Russia and South America. Within Europe, 73 
stringent controls such as a stamping out policy, movement restrictions and epidemiological 74 
surveillance measures have been in place since 1990 to prevent the spread of the disease, 75 
however, sporadic outbreaks have occurred, for example in Lithuania and Latvia, and the recent 76 
reoccurrence of CSF in Japan after 26 year absence highlight that CSFV remains an epizootic 77 
threat (van Oirschot, 2003; Schulz et al., 2017). CSF is amenable to control by vaccination 78 
with a number of different live attenuated vaccines available, the most widely used of which is 79 
the C strain vaccine (van Oirschot, 2003). However, the inability to distinguish serologically 80 
between animals that have been vaccinated or are infected with the virus (DIVA) means its use 81 
as an outbreak control tool is limited in CSF-free countries (Blome et al., 2017) .  The C strain 82 
vaccine was generated through serial passage in rabbits until it was no longer pathogenic. It 83 
provides a rapid and complete protection of pigs against infection and also prevents viral 84 
transmission within 5 days of vaccination (Leifer et al., 2009; Graham et al., 2012).  The 85 
immunological signalling cascades behind the early protection afforded by C Strain are poorly 86 
understood, but precede the adaptive response, where IFNγ+ CD8+ cells precede the detection 87 
of a humoral, virus neutralising response (Kaden and Lange, 2001; Dewulf et al., 2004; 88 
Franzoni et al., 2013). As the C strain vaccine has been the most widely used vaccine for CSFV 89 
to date, deciphering the precise innate immune signalling pathways underpinning its 90 
effectiveness may help shape and optimise the current generation of marker and subunit 91 
vaccines. To achieve a greater insight into the host response to vaccination with C strain, 92 
porcine microarrays were utilised to analyse the differences in gene expression in tonsil tissue 93 
between pigs that were vaccinated with C strain or given a mock inoculum. These pigs were 94 
then subsequently challenged with a virulent strain of CSFV five days post immunisation, thus 95 
before an effective adaptive response could be mounted. In this study we have examined 96 
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transcriptional changes in tonsils at early time points to identify subsets of genes that may be 97 
integral to this rapid protection and could support the induction of an early adaptive immune 98 
response. 99 
Materials and Methods 100 
Viruses. C strain CSFV (AC Riemser Schweinepestvakzine, Riemser Arzneimittel AG, Riems, 101 
Germany) and the virulent CSFV Brescia strain were propagated in PK15 cell monolayers. 102 
Both mock virus and virus stocks were prepared, and titers were determined, as described 103 
previously (Franzoni et al., 2013). 104 
Ethics statement. All animal work was approved by the Animal and Plant Health Agency  105 
(APHA) Animal Welfare and Ethical Review Board, and all procedures were conducted in 106 
accordance with the Animals  (Scientific Procedures) Act 1986  (United Kingdom) under 107 
project license permits PPL 70/6559. Each animal was euthanized on predetermined days by 108 
stunning and exsanguination.  109 
Animals. Eighteen Large White/Landrace crossbreed pigs of 9 weeks of age were randomly 110 
assigned to one of two groups. On day 0 the animals in group 1 (n = 9) were vaccinated with 2 111 
ml of C strain vaccine into the brachiocephalous muscle (as recommended by the 112 
manufacturer), and group 2 (n = 9) was intranasally inoculated with tissue culture supernatant 113 
(mock). For intranasal inoculations 1ml per nostril was administered using a mucosal 114 
atomization device (MAD300; Wolf Tory Medical, USA). On day 5 post vaccination (DPV), 115 
both groups were inoculated intranasally with 105 TCID50 of CSFV Brescia strain. EDTA anti-116 
coagulated blood samples were collected in Vacutainers (BD Biosciences) prior to and after 117 
challenge from the external jugular vein.  Three animals from each group were euthanized on 118 
dpv 5 (prior to challenge), dpv 8 and dpv10 and the tonsils were collected.  119 
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Clinical, hematological, and virological methods. The animals were inspected by the APHA 120 
Animal Sciences Unit staff twice daily  (am and pm), and 10 parameters relevant to an 121 
indication of CSF  (temperature, liveliness, body shape and tension, breathing, walking, skin, 122 
eye/conjunctiva, appetite, and defecation) were examined and scored as 0  (normal), to 3  123 
(severely altered; known CSF sign) (Everett et al., 2010) . A total clinical score for each animal 124 
was assigned twice daily, and their temperatures were monitored by rectal thermometer 125 
readings and recorded once daily. Peripheral blood leukocytes and CSFV RNA were monitored 126 
in EDTA blood samples collected every 3 days using volumetric flow cytometry and real-time 127 
reverse transcription-quantitative RT-PCR  (RRT-qPCR), respectively (Everett et al., 2010).  128 
Gene expression microarray analysis 129 
At days 5, 8 and 10 post-vaccination animals were euthanized, the tonsils removed, chopped 130 
into fine pieces and stored at -80oC in RNAlater (Sigma-Aldrich). RNA was extracted using 131 
MagMax 96 microarray total RNA isolation kit which includes a Turbo DNAse treatment to 132 
remove contaminating genomic DNA. Elimination of genomic DNA was confirmed by q-PCR 133 
detection of porcine β-actin gene with and without reverse transcription. The Ovation PicoSL 134 
WTA System v2 kit (NuGEN, Leek, The Netherlands) was used to amplify cDNA from 50ng 135 
total RNA. The MinElute Reaction Cleanup Kit (Qiagen) was used to purify cDNA, and 1 μg 136 
was then labelled using a one-color DNA labelling kit (NimbleGen, Madison, USA). For each 137 
sample, 4 μg labelled cDNA was hybridised to a custom NimbleGen 12 × 135 K porcine array 138 
designed using the Sus scrofa 10.2 genome build and incorporating a total of 19,351 genes, 139 
each represented on the array by a set of six different probes  (116,106 probes in total) (Edwards 140 
et al., 2017) . The microarray also contained a large number (24,179) of random probes. 141 
Hybridised arrays were scanned at 2 μm resolution on a microarray scanner (Agilent, 142 
Wokingham, UK). Microarray images were processed using DEVA v1.2.1 software to obtain 143 
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a pair report containing the signal intensity values for each probe. To correct for differences in 144 
the overall intensity levels between slides robust multi-array (RMA) normalization was used. 145 
Data was then processed using GeneSpring GX using the manufacturer’s guidelines. RMA 146 
normalized pair files were imported and empirical Bayesian unpaired comparison  (moderated 147 
t-test, P<0.05) combined with a Westfall and Young Permutation to correct for multiple testing 148 
was carried out to generate a list of genes with significantly altered expression between C strain 149 
and mock inoculated pigs of greater than twofold. The raw microarray data (background-150 
corrected signal) can be assessed at Gene Expression Omnibus (GEO accession GSE111486. 151 
Reviewer access code: mzurkuggzdylleh). 152 
Gene Ontology and Pathway Analysis 153 
To aid in the analysis of the data, where possible human orthologue of porcine genes were used 154 
for further analysis. Gene Ontology analysis was performed using BiNGO within Cytoscape 155 
3.2 (Shannon et al., 2003; Maere et al., 2005). BiNGO analysis was performed using a 156 
hypergeometric test with a Bejamini Hochberg False Discovery Rate correction and 157 
significance value of 0.05, the ontology file used was GO_Biological_Process. PANTHER 158 
Overrepresentation Analysis (release 20171205) was performed using the annotation 159 
Reactome version 58 (Release 20161207) using a Binomial test with a Bonferoni Correction 160 
for multiple comparison (Ashburner et al., 2000; Gene Ontology, 2015). Network analysis was 161 
performed using NetworkAnalyzer tool in Cytoscape, nodes and label sizes are mapped based 162 
on betweenness centrality (Shannon et al., 2003).  163 
 164 
Results 165 
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Vaccination, challenge and clinical observations 166 
Samples for transcriptomic analysis were generated from animals vaccinated, or mock 167 
inoculated, 5 days prior to challenge with virulent CSFV (Franzoni et al., 2013). Tonsil samples 168 
were collected prior to challenge at 5 dpv and also at day 8 and day 10 pv  (3 and 5 days post-169 
challenge (dpc))  (Fig. 1A). C strain vaccinated animals were protected from the challenge with 170 
no clinical signs or temperature increase detected. The mock inoculated animals had early 171 
clinical signs of CSF from 4-5 dpc and elevated rectal temperatures (Fig. 1B and C). CSFV 172 
RNA and leukopenia was detected in blood samples from 8 dpv in the mock inoculated animals 173 
but not in vaccinated animals (Fig. 1D and E). This level of protection corresponds with 174 
previous studies in that complete protection from challenge with CSFV was observed within 5 175 
days of vaccination, thus before the onset of an adaptive immune response, which then rapidly 176 
develops after challenge  (Graham et al., 2012). 177 
Intramuscular vaccination produces a robust transcriptional response in tonsil cells of 178 
naïve pigs. 179 
At day 5 post-vaccination (prior to challenge), when vaccinated pigs were compared to mock 180 
inoculated pigs, 448 genes were differentially regulated; 255 genes were down-regulated and 181 
193 genes upregulated (Table 1, Sup.Table 1). Gene Ontology analysis (Maere et al., 2005) 182 
highlighted over representation of gene categories associated with response to virus among the 183 
upregulated genes as expected since the C strain vaccine is a live, attenuated virus  (Fig. 2A). 184 
Among the downregulated genes a number of different metabolic processes were over-185 
represented (Fig. 2B).  186 
At day 8 pv, i.e. 3 dpc and thus when viral RNA was detected in the unvaccinated animals (Fig. 187 
1E) 138 genes were differentially regulated, with 118 genes significantly less expressed in 188 
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tonsils of C strain vaccinated pigs compared to mock inoculated pigs  (Table 2, Sup. Table 2). 189 
In terms of gene ontology over-representation, an inversion occurred whereby pathways 190 
associated with response to virus were now overrepresented in those pigs that were not 191 
vaccinated (Sup. Fig 1).  192 
At 10 dpv, thus 5 dpc, 142 genes were differentially regulated, with 126 of these genes 193 
expressed less in the vaccinated animals compared to the mock inoculated group (Table 3, Sup. 194 
Table 3). Ontology analysis yielded similar observations as was seen at day 8 with an over-195 
representation of pathways associated with a response to a virus (Sup. Fig 2) in pigs that were 196 
not vaccinated. Notably, among the few genes that were up regulated in the C strain vaccinated 197 
pigs was eomes, a gene that encodes a transcriptional regulator known to play a role in CD8+ 198 
T cell differentiation (Martinet et al., 2015). This corresponds with previously published data 199 
where CSFV specific CD8+ T cells were detected in the same animal cohort (Franzoni et al., 200 
2013).  201 
Specific sub-sets of genes fluctuate in response to CSFV regardless of strain virulence. 202 
Analysis of all the significantly differentially expressed genes at day 5, 8 and 10 post-203 
vaccination revealed a cohort of genes that were differentially expressed at all of the time 204 
points. This suggested that these genes were integral to the response to both the C strain vaccine 205 
and the virulent CSFV strain Brescia. These genes were significantly upregulated in C strain 206 
vaccinated pigs at 5 dpv (Fig. 3A). However, by day 8 and day 10 the expression of these genes 207 
in vaccinated animals had alleviated suggesting they were no longer induced. Remarkably, this 208 
same subset of genes was instead induced significantly in the mock inoculated animals at 8 209 
days (Fig. 3B) and 10 days (Fig. 3C) post-vaccination (3 and 5 days post-challenge) (Fig3D). 210 
The expression of these genes corresponds with exposure to either strain of the virus and may 211 
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play a key role in enabling vaccinated pigs to overcome challenge. Indeed, among this cohort 212 
are a number of genes coding for antiviral effectors, such as IFIT1, IFIT2, IFIT3, IFIT5 which 213 
encode proteins that directly interact with viral RNA preventing the initiation of translation 214 
(Schmeisser et al., 2010; Ablasser and Hornung, 2011; Pichlmair et al., 2011; Cho et al., 2013; 215 
Hsu et al., 2013; Wetzel et al., 2014), as well as MX1 and MX2, proteins that can directly 216 
prevent viral ribonucleoprotein complex formation (Jin et al., 1999; Salomon et al., 2007; 217 
Verhelst et al., 2012; Cai et al., 2013; He et al., 2014; Zhang et al., 2015; Wang et al., 2016). 218 
The increase in expression of the genes encoding these antiviral effectors, as well as other 219 
proteins involved in the innate immune response, such as RSAD2 (Viperin), DDX60 and 220 
DHX58, at the time of challenge may be integral to the early protection offered by C strain 221 
vaccination.   222 
The ISG15 pathway is activated in response to C strain vaccination. 223 
The proteins encoded by the subset of genes differentially expressed across all three time points 224 
were subjected to an interaction analysis using Cytoscape and pathways from the InnateDB 225 
database. This network analysis revealed that many of the proteins within this cohort are 226 
capable of directly interacting with at least one other protein in the cohort and also highlighted 227 
ISG15 as the best connected node within the network (Fig. 4).   This is likely to be expected 228 
given the nature of ISG15, which functions in a pathway similar to the ubiquitination pathway, 229 
in that ISG15 is conjugated to a range of host and non-host proteins modifying their function 230 
in a process known as ISGylation (Zhao et al., 2013). Indeed among our common cohort of 231 
genes differently expressed at all time points were a number of known ISG15 conjugation 232 
targets such as IFIT1-3, IFIT5, DHX58, MX1 (Zhao et al., 2005), as well as other components 233 
of the ISG15 pathway including key enzymes HERC5 and USP18, which are directly involved 234 
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in the ISGylation conjugation and deconjuguation process, respectively (Sadler and Williams, 235 
2008).  236 
Gene overrepresentation analysis using the Reactome Database identified the Interferon 237 
signalling pathway and also identified the ISG15 pathway as being significantly 238 
overrepresented across all time points (p< 4.04E-09, Sup. Table 4), albeit in different groups 239 
at each time point. It was overrepresented in C strain vaccinated pigs at 5 dpv (p < 5.99E-03, 240 
Sup. Table 5), but in mock inoculated pigs at day 8 (p< 1.83E-07, Sup. Table 6) and 10 dpv 241 
(p< 6.97E-06, Sup. Table 7).  242 
The early induction of the ISG15 pathway may play a key role in the early protection afforded 243 
by the C strain vaccination as it ensures that an innate immune response that is producing 244 
numerous antiviral effectors (IFIT1, IFIT2, IFIT3, IFIT5, MX1 and MX2) is elevated during 245 
this early window.  246 
 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
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Discussion 255 
Since its introduction in the early 1960’s the C strain vaccine, has proven remarkably effective 256 
and is still the most used vaccine to control CSFV in endemic settings for example in SE Asia  257 
(Brown and Bevins, 2018). It has been shown to stimulate an adaptive cell mediated immune 258 
response within 8 - 10 dpv (Franzoni et al., 2013). However, vaccinated pigs are protected 259 
already 5 dpv, with partial protection observed even earlier (Leifer et al., 2009, Graham et al., 260 
2012). Understanding the molecular mechanisms underpinning this early immunity may aid in 261 
the development of more effective, rapid vaccines and in the optimization of vaccines that are 262 
currently available. In this study we used a transcriptomic approach to identify a subset of genes 263 
that are regulated after both vaccination and challenge and that are linked to a distinct antiviral 264 
pathway that is up-regulated during this early protective window.  265 
Type I IFN is known to play a key role in generating a robust host immune response to viral 266 
infection and the according expression of interferon stimulated genes (ISG) with vaccination 267 
or challenge had been expected since it is known that CSFV is a strong inducer of type I IFNs 268 
(Cao et al., 2015). The interaction of type I IFN with CSFV has been extensively studied, not 269 
least as CSFV also exhibits ways to suppress type I IFN (Fiebach et al., 2011). However, the 270 
interferon response comprises of over 300 ISGs (Der et al., 1998) and the precise mechanism 271 
through which this signalling cascade mediates these numerous antiviral responses is yet to be 272 
fully elucidated. We focussed here on a set of genes that was significantly regulated across 273 
both studied conditions (vaccination and challenge) and was significantly regulated at all time 274 
points studied in this early period post exposure to either virus.  275 
Expression of the ISG15 gene has previously been shown to be induced in response to virulent 276 
strains of CFSV in vitro (Cai et al., 2017; Li et al., 2018), however, this is the first study to 277 
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demonstrate induction of the ISG15 pathway in response to vaccination with C strain in vivo 278 
and specifically that this induction occurs in the tonsil, the primary site of CSFV replication. 279 
Importantly, the ISG15 pathway was up-regulated in C strain vaccinated strains during the 280 
window in which a protective immune response exists and the adaptive immunity develops. 281 
Although the C strain vaccine was given intramuscularly it is well established that CSFV has 282 
a tropism for tonsil tissue which is the primary site of replication of CSFV (Gavier-Widen et 283 
al., 2012), the elevation of the ISG15 pathway in this specific tissue is ideally placed to prevent 284 
challenge by the most likely natural route of infection. 285 
ISG15 plays a central role in mediating IFN-induced host antiviral responses. ISG15 is a 15 286 
kDa protein that is covalently attached to its target proteins via the action of a group of 3 287 
enzymes (UBE1L, UBCH8 and HERC5), which are also induced in response to type I IFN. 288 
This pathway is similar to that of ubiquitination, however unlike ubiquitination, conjugation of 289 
ISG15 to host target proteins does not prime them for degradation but instead stabilises or 290 
activates them. Over 150 host ISG15 conjugation targets have been identified thus far (Zhao et 291 
al., 2005) Among this cohort of ISGylation targets are some anti-viral proteins whose mRNA 292 
has been identified as differentially regulated through our analysis such as IFIT1, IFIT2, IFIT3, 293 
IFIT5 MX1 and MX2. These proteins target a number of different aspects of the viral 294 
replication cycle such as RNA translation and virion assembly (Jin et al., 1999; Salomon et al., 295 
2007; Ablasser and Hornung, 2011; Pichlmair et al., 2011; Cai et al., 2013; Cho et al., 2013). 296 
Some of the proteins such as MX1, have direct antiviral activity against CSFV (He et al., 2014; 297 
Zhang et al., 2015), other proteins are known to be active against other Flaviviruses, such as 298 
IFIT2 which restricts growth of West Nile virus (Cho et al., 2013). Moreover, the free 299 
unconjugated form of the ISG15 has antiviral activity and can protect mice against another 300 
RNA (Toga-)virus, the Chikungunya virus infection (Werneke et al., 2011).  301 
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Conjugation of ISG15 to viral proteins results in their loss of function and the evolutionary 302 
importance of this pathway in controlling viral infection is demonstrated by the emerging 303 
number of viral proteins that have evolved to disrupt this pathway. For example, the NS1 304 
protein of influenza A and B viruses inhibits ISG15 conjugation (Yuan and Krug, 2001; Tang 305 
et al., 2010; Zhao et al., 2010; Zhao et al., 2013) and NSP2 of porcine reproductive and 306 
respiratory syndrome virus, another important pig pathogen, inactivates ISG15 (Sun et al., 307 
2012). 308 
Further to those proteins directly linked with the ISG15 pathway, we also saw the upregulation 309 
of a number of other ISGs. These included IFI44 which is known to have antiviral activity 310 
although the precise mechanism of action remains to be characterised (Power et al., 2015) and 311 
RSAD2 (Viperin) which inhibits many DNA and RNA viruses, including CSFV through 312 
interaction with the E2 structural protein (Li et al., 2017). Importantly, RSAD2 has also been 313 
implicated in DC maturation and CD4 cell activation (Sezin et al., 2017; Jang et al., 2018) and 314 
may thus be one of the genes that links the innate and adaptive immune system. One porcine 315 
gene LOC100157244 was differentially regulated that has not previously been characterised 316 
but is predicted to be a ATP-dependent RNA helicase similar to DDX60. This protein may be 317 
a novel component of the pig host’s immune response to viral infection and future work needs 318 
to focus on characterising this gene, as well as establishing if some of the other genes 319 
upregulated that have not yet been directly related to the ISG15 pathway could represent as yet 320 
uncharacterised ISG15 conjugation targets.  321 
The role of IFN I in CSFV infection has been discussed (Summerfield and Ruggli, 2015) and 322 
it is proposed that the type I IFNs contribute to the pathology of haemorrhagic fever. However, 323 
it is well known that IFN I induce anti-viral effects in cells that have been treated before 324 
infection, so that ISGs can be induced, and that a single dose IFN I does not induce a long 325 
I  re i
ew
15 
 
lasting anti-CSFV effect (Fernandez-Sainz et al., 2015). In light of our analysis, we propose a 326 
model whereby C strain vaccination is giving vaccinated pigs a head start during which a wide 327 
range of innate antiviral effectors are produced, which serve to contain viral replication, should 328 
exposure to a virulent strain of CSFV take place prior to the onset of adaptive responses. In 329 
naïve hosts, a virulent strain of CSFV will replicate faster, as the innate response cannot 330 
produce enough antiviral effectors in time to contain the infection (Fig. 5). While many of the 331 
proteins described have been shown to have direct antiviral activity against CSFV, this 332 
response is not necessarily specific to CSFV, but since C strain targets the tonsil, which is also 333 
the primary site of CFSV replication, it is particularly effective at protecting against CSFV. 334 
The up-regulation of the ISG15 pathway in unvaccinated pigs after CSFV Brescia challenge is 335 
most likely associated with the failed attempt of the immune system to induce an antiviral 336 
response after infection, contributing to clinical disease including leukopenia (Zhao et al., 337 
2013; Summerfield and Ruggli, 2015).    338 
 339 
  340 
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Figure 1: C Strain Vaccination and Subsequent Challenge: (A) Schematic outline of the 526 
vaccine/challenge study highlighting key time points of vaccination and challenge. Three 527 
animals per group were euthanized at day 5, 8 and 10 pv for sample acquisition (B) Mean 528 
clinical score data from both C strain vaccinated and mock inoculated animals from before the 529 
study commenced until completion. (C) Rectal temperatures of animals throughout the course 530 
of the study. (D) Peripheral blood leukocyte counts in EDTA blood samples throughout the 531 
study (E) CSFV RNA as detected in blood by reverse transcription-quantitative RT-PCR. Error 532 
bars indicate SD.   533 
Figure 2: Overrepresented Gene Ontologies in tonsils 5 days after vaccination: (A) Gene 534 
ontologies overrepresented as determined by the BiNGO Cytoscape application in the subset 535 
of genes upregulated in C-Strain vaccinated pigs at 5 days post vaccination. (B) Gene 536 
ontologies overrepresented in the subset of genes downregulated in C- strain vaccinated pigs 537 
at 5 days post vaccination. Hypergeometric Test used to determine significance (p<0.05). Level 538 
of significance indicated by yellow to orange colouring. 539 
Figure 3: Differential expression of a cohort of genes at identified at each time point: (A) 540 
Expression of a cohort of 14 genes at day 5 post vaccination comparing the C Strain vaccinated 541 
animals to those that received the mock inoculation. (B) Expression of a cohort of 14 genes at 542 
day 8 post vaccination (3 dpc) comparing the C Strain vaccinated animals to those that received 543 
the mock inoculation. (C) Expression of a cohort of 14 genes at day 10 post vaccination (5 dpc) 544 
comparing the C Strain vaccinated animals to those that received the mock inoculation. (D) 545 
Heat map showing the gene expression changes as they occurred over the course of the study. 546 
Expression values are from 3 pigs per condition per time point. Significance was determined 547 
using a moderated t-test p< 0.05 considered as significant. 548 
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Figure 4: Network analysis of Co-expressed Genes: Network assembled from 14 gene cohort 549 
significantly differentially regulated at each time point. Network based on interactions defined 550 
in the InnateDB. Nodes and label sizes are mapped based on betweenness centrality. Network 551 
assembled using Cytoscape 3.2 552 
Figure 5: Head Start Immunity Model: Upon vaccination with C strain, the induction of 553 
interferon results in induction of ISGs, including the ISG15 antiviral pathway activation 554 
resulting in the induction and activation via ISGylation of a wide variety of antiviral effectors. 555 
These antiviral effectors accumulate over the 5 days post vaccination, priming the host in an 556 
antiviral state and, for example via induction of RSAD2, instigating the adaptive immune 557 
response. If during this window a virulent strain of CSFV attempts to infect the host, the 558 
multitude of antiviral effectors are already present within the cell and can immediately prevent 559 
the replication of the virus and ultimately assist in preventing the establishment of infection. 560 
Without prior vaccination, replication of a virulent strain of CFSV is allowed as although the 561 
antiviral effectors of IFN and ISG15 pathways are induced by the virulent virus these cannot 562 
keep pace with the replication rate of virulent strains of CSFV and thus are not able to 563 
sufficiently control viral replication before adaptive responses can be activated, leading to the 564 
onset of clinical disease. 565 
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